SCHEMBL20624711

SCHEMBL20624711

Cc1cnccc1-c1cnccc1C(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RPS6KA3 P51812 1/20 0.49
▸ LATS1 O95835 3/20 0.40
▸ LATS2 Q9NRM7 2/20 0.40
▸ CCNC P24863 2/20 0.40
▸ CDK8 P49336 2/20 0.40
▸ MAOA P21397 1/20 0.38
▸ MAOB P27338 1/20 0.38
▸ LIMK1 P53667 1/20 0.37
▸ GRM4 Q14833 1/20 0.37
▸ CDC25B P30305 1/20 0.37
▸ CYP19A1 P11511 1/20 0.36
▸ CYP1A2 P05177 3/20 0.36
▸ METAP2 P50579 1/20 0.36
▸ SIRT3 Q9NTG7 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ CYP3A4 P08684 3/20 0.35
▸ CYP2E1 P05181 1/20 0.35
▸ CYP2C8 P10632 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2A6 P11509 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21104868 0.85 RPS6KA3 (0.46) RPS6KA3MAOAMAOBLIMK1CYP1A2
SCHEMBL2737302 0.81 RPS6KA3 (0.43) RPS6KA3LATS1LATS2CYP1A2SIRT3
SCHEMBL3423341 0.81 CCNC (0.50) RPS6KA3LATS1LATS2CCNCCDK8
SCHEMBL19059572 0.77 CYP17A1 (0.46) CCNCCDK8GRM4CYP1A2SIRT3
SCHEMBL21105124 0.76 RPS6KA3 (0.60) RPS6KA3LATS1LATS2MAOAMAOB
SCHEMBL17121954 0.75 RPS6KA3 (0.55) RPS6KA3CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6408659 0.74 RPS6KA3 (0.44) RPS6KA3LATS1MAOAMAOBLIMK1
SCHEMBL24600358 0.74 RPS6KA3 (0.43) RPS6KA3MAOAMAOBLIMK1CDC25B
SCHEMBL6910260 0.73 RPS6KA3 (0.57) RPS6KA3MAOAMAOBLIMK1CYP1A2
SCHEMBL20744313 0.73 RPS6KA3 (0.40) RPS6KA3LATS1CCNCCDK8CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10547014-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2020-01-28 — — US disclosed
US-20190006606-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux North America, Inc. 2019-01-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10547014-B2 Composition of matter for use in organic light-emitting diodes CRY2, ALDH1A2, CYBA RPS6KA3 2729/4885LATS1 2663/4885LATS2 2287/4885
US-20190006606-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, ALDH1A2, CYBA RPS6KA3 2729/4885LATS1 2663/4885LATS2 2287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback